Refuge Bio Turns to China for $25M Financing of Precision CRISPR R&D – Xconomy
Xconomy |
Refuge Bio Turns to China for $25M Financing of Precision CRISPR R&D
Xconomy Xconomy San Francisco —. Refuge Biotechnologies, a company researching ways to use CRISPR gene editing to make cancer treatment more precise, has raised $25 million in financing to continue work on its preclinical drug pipeline. China-based 3SBio and … |
